Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Therapeutics To Regain Control Of VB10.Neo Program

Nov 7 (Reuters) - Nykode Therapeutics ASA  NYKD.OL :
    * NYKODE THERAPEUTICS TO REGAIN CONTROL OF VB10.NEO PROGRAM
    * NYKODE THERAPEUTICS ASA - IS NOT REQUIRED TO REFUND ANY
UPFRONT
PAYMENTS OR MAKE ANY FUTURE PAYMENTS TO GENENTECH ON TERMINATION
    * NYKODE THERAPEUTICS ASA - EXISTING COLLABORATION AND
LICENSING
AGREEMENT SIGNED SEPTEMBER 2020 WILL TERMINATE EFFECTIVE JANUARY
6, 2025

Source text:  ID:nObiq2jhqa 
Further company coverage:  NYKD.OL 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Nykode Therapeutics ASA

See all news